Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma

[1]  Shanta M. Messerli,et al.  4SC-202 as a Potential Treatment for the Pediatric Brain Tumor Medulloblastoma , 2017, Brain sciences.

[2]  James M. Murphy,et al.  The secret life of kinases: insights into non-catalytic signalling functions from pseudokinases. , 2017, Biochemical Society transactions.

[3]  Xin Hu,et al.  PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma , 2017, World Journal of Surgical Oncology.

[4]  Etienne Z. Gnimpieba,et al.  Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors , 2017, Molecular Cancer Research.

[5]  Jeffrey T Leek,et al.  Reproducible RNA-seq analysis using recount2 , 2017, Nature Biotechnology.

[6]  A. Wodarz,et al.  PTK7 Faces the Wnt in Development and Disease , 2017, Front. Cell Dev. Biol..

[7]  Samuel A. Williams,et al.  A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions , 2017, Science Translational Medicine.

[8]  Won-Sik Shin,et al.  Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells , 2016, Oncotarget.

[9]  T. Park,et al.  LPEseq: Local-Pooled-Error Test for RNA Sequencing Experiments with a Small Number of Replicates , 2016, PloS one.

[10]  Xiu-Yun Tian,et al.  PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance , 2016, Oncology reports.

[11]  J. Borg,et al.  The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway* , 2015, The Journal of Biological Chemistry.

[12]  Won-Sik Shin,et al.  Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis. , 2015, Biochimica et biophysica acta.

[13]  J. Borg,et al.  Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer , 2015, PloS one.

[14]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[15]  Yongxiang Yin,et al.  PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis. , 2014, International journal of clinical and experimental pathology.

[16]  Ji-Hee Kim,et al.  Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer. , 2014, Oncology reports.

[17]  H. Ryu,et al.  High Expression of Protein Tyrosine Kinase 7 Significantly Associates with Invasiveness and Poor Prognosis in Intrahepatic Cholangiocarcinoma , 2014, PloS one.

[18]  Jun Qin,et al.  A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties. , 2014, The Biochemical journal.

[19]  D. Frank,et al.  PTK7 modulates Wnt signaling activity via LRP6 , 2014, Development.

[20]  Won-Sik Shin,et al.  Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma , 2013, Cancer science.

[21]  Claudia Baumann,et al.  Tyrosine kinase expression profile in clear cell renal cell carcinoma , 2012, World Journal of Urology.

[22]  N. Tolwinski,et al.  PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling , 2011, The EMBO journal.

[23]  Li-Xuan Qin,et al.  Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. , 2011, Cancer research.

[24]  F. Puppo,et al.  Protein tyrosine kinase 7 has a conserved role in Wnt/β‐catenin canonical signalling , 2011, EMBO reports.

[25]  D. Shangguan,et al.  Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway , 2010, PloS one.

[26]  F. Puppo,et al.  The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. , 2010, Blood.

[27]  I. Shnitsar,et al.  PTK7 recruits dsh to regulate neural crest migration , 2008, Development.

[28]  Jae-Won Jung,et al.  Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. , 2008, Biochemical and biophysical research communications.

[29]  M. Tessier-Lavigne,et al.  PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates , 2004, Nature.

[30]  Michael A. Choti,et al.  A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.

[31]  R. Spritz,et al.  Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma , 1997, International journal of cancer.

[32]  H. Lee,et al.  Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG. , 1996, Journal of biochemistry.

[33]  A. Ullrich,et al.  Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. , 1995, Oncogene.

[34]  R. Spritz,et al.  A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. , 1993, Oncogene.

[35]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[36]  A. Jemal,et al.  Global Cancer Statistics , 2011 .